PhD Aleša Bricelj
no.: 53656

researcher – active in research organisation

alesa.bricelj at sign

ffa.uni-lj.si

Research activity

Code	Science	Field	Subfield
1.09.00	Natural sciences and mathematics	Pharmacy

Bibliography Representative bibliographic units | Personal | COBISS+

Evaluation (metodology)

Points

261.86

A''

96.64

154.18

A1/2

217.67

CI10

458

CImax

134

h10

1.01

Data for the last 5 years (citations for the last 10 years) on October 15, 2025; Data for score A3 calculation refer to period 2020-2024

Data for ARIS tenders ( 23.05.2022 – Target research programmes, archive )

Database	Linked records	Citations	Pure citations	Average pure citations
WoS	12	442	413	34.42
Scopus	12	487	455	37.92

Education

Level of education	Professional title	Study subject	Faculty	Year
2nd cycle master's degree	B. Sc.		University of Ljubljana, Faculty of Pharmacy	2019
Doctoral degree	Ph. D.		University of Ljubljana, Faculty of Pharmacy	2023

Doctoral dissertations and other final papers Show

Employments

Type of employment	Research org.	Research group	Date of employment	Position	Role	Title
Full time employment (100%, RD:100%)	University of Ljubljana, Faculty of Pharmacy	Chair for Pharmaceutical Chemistry	7/1/2019	Researcher	Researcher	Lecturer

Research projects Legend

no.	Code	Title	Period	Head	No. of publications
1.	N1-0417	Mono- and multivalent inhibitors of galectin-8 in tumour-associated (lymph)angiogenesis (MULTIGAL-8)	3/1/2025 - 9/30/2028	PhD Marko Anderluh	824
2.	N1-0331	A double whammy for the NF-κB signalling pathway: development of TAK1 and IKKβ degraders against inflammation-driven diseases	1/1/2024 - 12/31/2027	PhD Izidor Sosič	1,086
3.	J1-50037	Development of CDK1-selective degraders for the treatment of T-cell malignancies	10/1/2023 - 9/30/2026	PhD Izidor Sosič	1,278
4.	J7-4420	Selective mechanical removal of bacterial biofilms by conjugated magnetic nanoparticles	10/1/2022 - 9/30/2025	PhD Aleš Berlec	4,253
5.	J1-2483	Radiopharmaceuticals with antagonistic activity on CCK2R	9/1/2020 - 8/31/2023	PhD Marko Anderluh	1,164
6.	J1-2485	The kiss of death for key apoptosis players: development of BCL-2 and BAX PROTACs	9/1/2020 - 8/31/2023	PhD Izidor Sosič	1,100
7.	J3-1749	Mesenchymal stem cells-the keepers of tissue endogenous regenerative capacity facing up to aging of the musculoskeletal system	7/1/2019 - 6/30/2023	PhD Janja Zupan	2,551
8.	N1-0098	Discovery and mechanism of action of novel hEag1 potassium channel lead molecules with anti-cancer activity	1/1/2019 - 12/31/2022	PhD Lucija Peterlin Mašič	979
9.	N1-0068	Identification of non-peptidic inhibitors of the immunoproteasome using fragment based drug discovery methods	11/1/2017 - 10/31/2020	PhD Stanislav Gobec	2,028

ARIS research and infrastructure programmes Legend

no.	Code	Title	Period	Head	No. of publications
1.	P1-0208	Medicinal chemistry - drug design, synthesis and evaluation	1/1/2022 - 12/31/2027	PhD Stanislav Gobec	5,846